Sleep & Recovery

DSIP

Delta Sleep-Inducing Peptide

Sleep architecture regulation and stress resilience

Research Status: Preclinical + limited Eastern European human studies Delta-sleep-inducing peptide Somnogen
Mechanism of Action

How it works

DSIP modulates sleep by influencing GABA receptors and normalizing the hypothalamic-pituitary-adrenal (HPA) axis. It reduces corticotropin (ACTH) release under stress, blunts cortisol response, and promotes delta-wave sleep architecture.

Areas of Research

What the research explores

In published research, DSIP has been studied in connection with the following. These describe findings reported in the literature — not approved uses, claims, or outcomes to expect.

  • Promotes deep, restorative delta-wave sleep
  • Reduces cortisol and normalizes HPA axis function
  • Antioxidant and anti-tumor properties
  • Reduces withdrawal symptoms in alcohol and opioid dependence
  • Normalizes disturbed sleep patterns
  • Reduces chronic pain perception
Research Highlight

DSIP was discovered in 1974 and has generated extensive research showing it normalizes dysregulated sleep-wake cycles and HPA axis activity, particularly in stress-related disorders.

Safety Profile

Adverse events & gaps

Well-tolerated in available studies. Non-addictive mechanism of action.



Stay Informed on
Peptide Research

Research summaries, newly documented peptides, and clinical trial updates delivered to your inbox.

No spam. Unsubscribe at any time.